Pacific Radiance Valuation
Is RXS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RXS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RXS (SGD0.05) is trading below our estimate of fair value (SGD1.3)
Significantly Below Fair Value: RXS is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RXS?
Key metric: As RXS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is RXS's PE Ratio? | |
|---|---|
| PE Ratio | 1.8x |
| Earnings | US$27.40m |
| Market Cap | US$51.56m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | 2.9x |
| PEG Ratio | -0.02x |
Price to Earnings Ratio vs Peers
How does RXS's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 10.5x | ||
WPC Vallianz Holdings | 6.4x | n/a | S$48.5m |
M05 MTQ | 12.6x | n/a | S$52.8m |
DU4 Mermaid Maritime | 15.4x | 44.0% | S$188.0m |
BTP Baker Technology | 7.8x | n/a | S$125.8m |
RXS Pacific Radiance | 1.8x | -84.7% | S$69.5m |
Price-To-Earnings vs Peers: RXS is good value based on its Price-To-Earnings Ratio (1.8x) compared to the peer average (10.5x).
Price to Earnings Ratio vs Industry
How does RXS's PE Ratio compare vs other companies in the Asian Energy Services Industry?
Price-To-Earnings vs Industry: RXS is good value based on its Price-To-Earnings Ratio (1.8x) compared to the Asian Energy Services industry average (14.9x).
Price to Earnings Ratio vs Fair Ratio
What is RXS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 1.8x |
| Fair PE Ratio | 1.6x |
Price-To-Earnings vs Fair Ratio: RXS is expensive based on its Price-To-Earnings Ratio (1.8x) compared to the estimated Fair Price-To-Earnings Ratio (1.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
AnAn International
S$21.2m
An investment holding company, trades in petrochemical, fuel oil, and petroleum products in Singapore, the People’s Republic of China, Europe, and internationally.
Y35
S$0.005
7D
-16.7%
1Y
-70.6%
Sinostar PEC Holdings
S$83.8m
An investment holding company, produces and supplies petrochemical products in the People’s Republic of China.
C9Q
S$0.13
7D
-0.8%
1Y
-3.0%
Baker Technology
S$125.8m
An investment holding company, manufactures and provides specialized marine offshore equipment and services for the oil and gas industry in Singapore, China, rest of the Asia Pacific, Africa, the Middle East, the Americas, and Europe.
BTP
S$0.62
7D
0.8%
1Y
13.8%